SUSQUEHANNA INTERNATIONAL GROUP, LLP - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 35 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,000
-57.1%
12,100
+2.0%
0.00%
Q1 2022$7,000
-89.1%
11,860
-86.9%
0.00%
Q4 2021$64,000
-86.6%
90,704
-69.1%
0.00%
Q3 2021$479,000
+3.7%
293,844
+26.5%
0.00%
Q2 2021$462,000
-19.2%
232,362
+61.6%
0.00%
Q4 2020$572,000
+420.0%
143,750
+864.0%
0.00%
Q4 2019$110,000
+111.5%
14,912
+28.5%
0.00%
Q3 2019$52,00011,6050.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders